Early research (Phase 1)Active Not RecruitingNCT03805932
What this trial is testing
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia
Who this might be right for
Hairy Cell Leukemia
National Cancer Institute (NCI) 18